Sanner Group’s Big Move: Acquires Gilero To Grow Global Medical Device Line

Integrating Gilero into Sanner’s portfolio will significantly boost its capabilities, establishing Sanner as a top-tier provider of comprehensive services in drug delivery, diagnostics, and medtech devices. Gilero, a well-regarded CDMO in medical devices and drug delivery systems, brings advanced expertise in design, development, assembly, packaging, and contract manufacturing. This addition will enhance Sanner’s cohesive service offering. Furthermore, Gilero's skilled engineering team, based in the United States, Mexico, and Ireland, will extend Sanner’s presence and influence across both sides of the Atlantic.

Sanner is evolving its CDMO (Contract Development and Manufacturing Organization) offerings by blending innovative agility and strategic thinking with its rich heritage in primary healthcare packaging. Known for having the world's most extensive range of desiccant packaging and moisture control solutions, Sanner's acquisition of Gilero is a key move in its global strategy to boost and expand its comprehensive CDMO services. 

With new facilities and enhanced capabilities in the US, Germany, and Asia, Sanner solidifies its role as a leading global CDMO, delivering end-to-end services across major international markets. Alvarez & Marsal served as financial advisors, Deloitte provided tax structuring advice, and Norton Rose Fulbright handled legal matters for Sanner. Gilero received advisory support from Alira Health, with Hutchison PLLC overseeing its legal affairs.

Hans-Willem van Vliet, CEO of Sanner Group, said in a statement, “Gilero is the perfect fit for the ambitions of Sanner in our journey to become a leading global provider of customer-specific solutions in medical technology, diagnostics, pharmaceuticals and consumer healthcare. Following the acquisition of Springboard Pro late last year which strengthened our offering across the entire medical device development process, Gilero now expands our manufacturing and end-to-end capabilities in the US. Gilero will also broaden Sanner’s production facilities in the US to offer onsite production capabilities for our desiccant healthcare packaging solutions.”

He continued, “ Gilero’s commitment to providing exceptional service to its customers aligns with our long-standing dedication to support our clients. Additionally, with a greater global footprint, notably across the US and Mexico in key biopharma and medtech hubs, we foster greater collaboration with partners and can mitigate global supply chain issues by providing our services at a local level. We are excited to welcome the Gilero team to Sanner as we continue to deliver on excellence at all stages of the product life cycle.”

Ted Mosler, Co-Founder and Chief Executive Officer of Gilero, commented “We are thrilled to join forces with Sanner, offering our customers the advantages of 130 years of market leadership and quality, along with their extensive manufacturing footprint across Europe and Asia. We now offer in-house injection moulding services across the globe, and we are already embarking on opening an injection moulding facility in North Carolina to further vertically integrate our operations and better serve our customers. 

He further added, “By leveraging Sanner’s longstanding manufacturing expertise and international presence, our customers will benefit from expanded capabilities, including enhanced international manufacturing facilities and global-scale injection moulding. Together, we will be a truly global CDMO from design to delivery for our Pharmaceutical and MedTech customers, helping patients worldwide.”